Related Experiment Videos
Stem cell therapy in severe pediatric motility disorders
Conor J McCann1, Osvaldo Borrelli2, Nikhil Thapar3
1Stem Cells and Regenerative Medicine, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.
Insights
Stem cell therapy shows promise for pediatric gastrointestinal motility disorders. Human enteric neural stem cells (ENSCs) successfully engrafted in animal models, offering hope for functional recovery and new treatments.
Area of Science:
- Gastroenterology and Regenerative Medicine
- Developmental Biology
- Neuroscience
Background:
- Pediatric gastrointestinal motility disorders are severe conditions impairing enteric neuromuscular function.
- Current therapeutic options for these disorders are limited.
- Stem cell-based treatments offer a promising avenue for improved or curative therapies.
Purpose of the Study:
- To evaluate the potential of human enteric neural stem cells (ENSCs) for treating pediatric gastrointestinal motility disorders.
- To assess the engraftment and functional rescue capabilities of transplanted ENSCs in vivo.
Main Methods:
- Harvesting, propagation, and transplantation of human-derived ENSCs.
- In vivo transplantation studies in animal models of enteric neuropathy.
- Assessment of ENSC engraftment and functional recovery in recipient intestines.
Main Results:
- Successful demonstration of harvesting, propagation, and transplantation of human ENSCs.
- Confirmation of ENSC engraftment within the recipient intestine of animal models.
- Evidence of functional rescue in animal models following ENSC transplantation.
Conclusions:
- Human ENSCs are capable of engraftment and functional rescue in animal models of enteric neuropathy.
- Stem cell-based therapies, including pluripotent stem cell-derived cells and pharmacological modulation, hold significant potential for clinical application in treating pediatric gastrointestinal motility disorders.
- These findings pave the way for future clinical translation of stem cell therapies for these debilitating conditions.
Abstract:
Pediatric gastrointestinal motility disorders represent a range of severe developmental or acquired conditions that disrupt enteric neuromuscular function. Current medical and surgical therapeutic options are very limited but recent advances have highlighted the possibility of improved or curative stem cell-based treatments. Not only has the ability to harvest, propagate and transplant human-derived enteric neural stem cells (ENSCs) been demonstrated but recent in vivo transplantation studies have confirmed that ENSCs are capable of engraftment within recipient intestine of animal models of enteric neuropathy and effecting functional rescue. Pluripotent stem cell-derived cells and pharmacological modulation of both endogenous and transplanted neural stem cells have further enhanced the exciting prospect of clinical application of such stem cell-based therapies in the near future.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Gastrointestinal Motility Disorders
Stem Cell Culture
Adult Stem Cells
iPS Cell Differentiation